In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic ... weeks. Participants also lost 12 to 15 pounds in clinical trials, though it’s not a weight loss ...

Ozempic is taken once per week, on the same day each week, as prescribed by a health care professional. It may be taken with or without food. Weight loss is a common side effect seen in those ...

According to Wegovy’s manufacturer, Wegovy is currently the No. 1 prescribed medication for weight loss in the United States. Like Ozempic, Wegovy is an injectable medication used once per week.

Reduces A1C levels by 1.9% to 2.2% over 40 weeks. Participants also lost 12 to 15 pounds in clinical trials, though it’s not a weight loss medication ... provider or the Ozempic medication ...